Adjuvant exemestane with ovarian suppression in premenopausal breast cancer O Pagani, MM Regan, BA Walley, GF Fleming, M Colleoni, I Láng, ... New England Journal of Medicine 371 (2), 107-118, 2014 | 934 | 2014 |
Incidence and associations of parental and child posttraumatic stress symptoms in pediatric patients MA Landolt, M Vollrath, K Ribi, HE Gnehm, FH Sennhauser Journal of Child Psychology and Psychiatry 44 (8), 1199-1207, 2003 | 422 | 2003 |
Outcome of craniopharyngioma in children: long-term complications and quality of life A Poretti, MA Grotzer, K Ribi, E Schönle, E Boltshauser Developmental medicine and child neurology 46 (4), 220-229, 2004 | 353 | 2004 |
Brief report: Posttraumatic stress disorder in parents of children with newly diagnosed type 1 diabetes MA Landolt, K Ribi, J Laimbacher, M Vollrath, HE Gnehm, FH Sennhauser Journal of Pediatric Psychology 27 (7), 647-652, 2002 | 230 | 2002 |
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international … RA Stahel, O Riesterer, A Xyrafas, I Opitz, M Beyeler, A Ochsenbein, ... The Lancet Oncology 16 (16), 1651-1658, 2015 | 225 | 2015 |
Outcome of medulloblastoma in children: long-term complications and quality of life K Ribi, C Relly, MA Landolt, FD Alber, E Boltshauser, MA Grotzer Neuropediatrics 36 (06), 357-365, 2005 | 203 | 2005 |
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined … J Bernhard, W Luo, K Ribi, M Colleoni, HJ Burstein, C Tondini, G Pinotti, ... The Lancet Oncology 16 (7), 848-858, 2015 | 186 | 2015 |
Meeting the decision-making preferences of patients with breast cancer in oncology consultations: impact on decision-related outcomes R Brown, P Butow, M Wilson-Genderson, J Bernhard, K Ribi, I Juraskova Journal of clinical oncology 30 (8), 857-862, 2012 | 174 | 2012 |
Treatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trials P Saha, MM Regan, O Pagani, PA Francis, BA Walley, K Ribi, J Bernhard, ... Journal of clinical oncology 35 (27), 3113-3122, 2017 | 147 | 2017 |
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29) D Koeberle, JF Dufour, G Demeter, Q Li, K Ribi, P Samaras, P Saletti, ... Annals of oncology 27 (5), 856-861, 2016 | 137 | 2016 |
Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: patient-reported outcomes in the suppression of … K Ribi, W Luo, J Bernhard, PA Francis, HJ Burstein, E Ciruelos, M Bellet, ... Journal of Clinical Oncology 34 (14), 1601-1610, 2016 | 136 | 2016 |
Interrupting endocrine therapy to attempt pregnancy after breast cancer AH Partridge, SM Niman, M Ruggeri, FA Peccatori, HA Azim Jr, ... New England journal of medicine 388 (18), 1645-1656, 2023 | 132 | 2023 |
The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster … F Strasser, D Blum, R Von Moos, R Cathomas, K Ribi, S Aebi, D Betticher, ... Annals of Oncology 27 (2), 324-332, 2016 | 130 | 2016 |
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study … G Henke, M Knauer, K Ribi, S Hayoz, MA Gérard, T Ruhstaller, ... Trials 19, 1-28, 2018 | 126 | 2018 |
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial M Colleoni, W Luo, P Karlsson, J Chirgwin, S Aebi, G Jerusalem, P Neven, ... The lancet oncology 19 (1), 127-138, 2018 | 117 | 2018 |
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected … M Ruggeri, E Pagan, V Bagnardi, N Bianco, E Gallerani, K Buser, ... The breast 47, 85-92, 2019 | 116 | 2019 |
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib … GA Pesce, D Klingbiel, K Ribi, A Zouhair, R Von Moos, M Schlaeppi, ... European Journal of Cancer 48 (3), 377-384, 2012 | 110 | 2012 |
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial KA Phillips, K Ribi, Z Sun, A Stephens, A Thompson, V Harvey, ... The Breast 19 (5), 388-395, 2010 | 99 | 2010 |
Predictors of coping strategy selection in paediatric patients MA Landolt, M Vollrath, K Ribi Acta Paediatrica 91 (9), 954-960, 2002 | 83 | 2002 |
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial KA Phillips, J Aldridge, K Ribi, Z Sun, A Thompson, V Harvey, ... Breast cancer research and treatment 126, 221-226, 2011 | 70 | 2011 |